Social Media Content of Idiopathic Pulmonary Fibrosis Groups and Pages on Facebook: Cross-sectional Analysis.

idiopathic pulmonary fibrosis internet interstitial lung disease patient education social media

Journal

JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345

Informations de publication

Date de publication:
31 05 2021
Historique:
received: 08 09 2020
accepted: 17 04 2021
revised: 25 11 2020
entrez: 31 5 2021
pubmed: 1 6 2021
medline: 6 11 2021
Statut: epublish

Résumé

Patients use Facebook as a resource for medical information. We analyzed posts on idiopathic pulmonary fibrosis (IPF)-related Facebook groups and pages for the presence of guideline content, user engagement, and usefulness. The objective of this study was to describe and analyze posts from Facebook groups and pages that primarily focus on IPF-related content. Cross-sectional analysis was performed on a single date, identifying Facebook groups and pages resulting from separately searching "IPF" and "idiopathic pulmonary fibrosis." For inclusion, groups and pages needed to meet either search term and be in English, publicly available, and relevant to IPF. Every 10th post was assessed for general characteristics, source, focus, and user engagement metrics. Posts were analyzed for presence of IPF guideline content, useful scientific information (eg, scientific publications), useful support information (eg, information about support groups), and potentially harmful information. Eligibility criteria were met by 12 groups and 27 pages, leading to analysis of 523 posts. Of these, 42% contained guideline content, 24% provided useful support, 20% provided useful scientific information, and 5% contained potentially harmful information. The most common post source was nonmedical users (85%). Posts most frequently focused on IPF-related news (29%). Posts containing any guideline content had fewer likes or comments and a higher likelihood of containing potentially harmful content. Posts containing useful supportive information had more likes, shares, and comments. Facebook contains useful information about IPF, but posts with misinformation and less guideline content have higher user engagement, making them more visible. Identifying ways to help patients with IPF discriminate between useful and harmful information on Facebook and other social media platforms is an important task for health care professionals.

Sections du résumé

BACKGROUND
Patients use Facebook as a resource for medical information. We analyzed posts on idiopathic pulmonary fibrosis (IPF)-related Facebook groups and pages for the presence of guideline content, user engagement, and usefulness.
OBJECTIVE
The objective of this study was to describe and analyze posts from Facebook groups and pages that primarily focus on IPF-related content.
METHODS
Cross-sectional analysis was performed on a single date, identifying Facebook groups and pages resulting from separately searching "IPF" and "idiopathic pulmonary fibrosis." For inclusion, groups and pages needed to meet either search term and be in English, publicly available, and relevant to IPF. Every 10th post was assessed for general characteristics, source, focus, and user engagement metrics. Posts were analyzed for presence of IPF guideline content, useful scientific information (eg, scientific publications), useful support information (eg, information about support groups), and potentially harmful information.
RESULTS
Eligibility criteria were met by 12 groups and 27 pages, leading to analysis of 523 posts. Of these, 42% contained guideline content, 24% provided useful support, 20% provided useful scientific information, and 5% contained potentially harmful information. The most common post source was nonmedical users (85%). Posts most frequently focused on IPF-related news (29%). Posts containing any guideline content had fewer likes or comments and a higher likelihood of containing potentially harmful content. Posts containing useful supportive information had more likes, shares, and comments.
CONCLUSIONS
Facebook contains useful information about IPF, but posts with misinformation and less guideline content have higher user engagement, making them more visible. Identifying ways to help patients with IPF discriminate between useful and harmful information on Facebook and other social media platforms is an important task for health care professionals.

Identifiants

pubmed: 34057425
pii: v7i5e24199
doi: 10.2196/24199
pmc: PMC8204239
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e24199

Informations de copyright

©Andrew Kochan, Shaun Ong, Sabina Guler, Kerri A Johannson, Christopher J Ryerson, Gillian C Goobie. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 31.05.2021.

Références

Oral Oncol. 2016 Jun;57:e6-7
pubmed: 27160026
Surg Obes Relat Dis. 2018 Dec;14(12):1897-1902
pubmed: 30274739
Respir Med. 2007 Jun;101(6):1350-4
pubmed: 17107778
Can J Diabetes. 2017 Feb;41(1):97-101
pubmed: 28126155
Biom J. 2015 Sep;57(5):867-84
pubmed: 26059498
J Med Internet Res. 2013 Apr 23;15(4):e85
pubmed: 23615206
Int J Environ Res Public Health. 2019 Oct 09;16(20):
pubmed: 31600907
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
J Med Internet Res. 2011 Feb 04;13(1):e16
pubmed: 21371990
J Pediatr Surg. 2016 Nov;51(11):1766-1771
pubmed: 27522307
Lancet. 2020 Mar 21;395(10228):942-943
pubmed: 32171075
Ann Am Thorac Soc. 2019 May;16(5):572-579
pubmed: 30608877
Fam Med. 2015 Mar;47(3):222-6
pubmed: 25853534
Prev Chronic Dis. 2015 Jan 29;12:E11
pubmed: 25633486
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19
pubmed: 26177183
N Engl J Med. 2012 May 24;366(21):1968-77
pubmed: 22607134
Patient Educ Couns. 2013 Sep;92(3):426-31
pubmed: 23899831
Am J Respir Crit Care Med. 2016 Jul 15;194(2):218-25
pubmed: 26849779

Auteurs

Andrew Kochan (A)

Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Shaun Ong (S)

Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Sabina Guler (S)

Department of Pulmonary Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Kerri A Johannson (KA)

Division of Respiratory Medicine, Department of Medicine, University of Calgary, Calgary, AB, Canada.

Christopher J Ryerson (CJ)

Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Centre for Heart Lung Innovation, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Gillian C Goobie (GC)

Clinician Investigator Program, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH